ÖZGÜR MEHMET YİS, Mine Busra PEHLİVAN, Guler BUGDAYCİ, Neslihan YUCE

Evaluation of Bio-Rad D-10® and arkray adams HA-8160® HPLC analyzers in HbA1c measurement

Glycosylated hemoglobin A1c (HbA1c) is an important parameter used for the assessment of time-dependent glycemic status and the diagnosis and follow-up of diabetes. This study aimed to evaluate the analytical performance of two HPLC analyzers, the Bio-Rad D-10®, and the Arkray Adams HA-8160®. Accuracy and imprecision studies were conducted, and a method comparison study was performed with 105 samples. Samples were collected on five consecutive days and measured on both analyzers within two hours. Bland-Altman and regression analyses were used for statistical evaluation of the data. Low and high-level within-day CV values were calculated as 1.22% and 0.60% for the Arkray analyzer and 1.2% and 0.30% for the Bio-Rad analyzer, respectively. They were calculated as 1.27% and 2.52% for the Arkray analyzer and 2.32% and 3.44% for the Bio-Rad analyzer, respectively, between days. The within-day CV values for both analyzers were below the limit of 2.5% specified by the International Federation of Clinical Chemistry (IFCC). The bias average for three months was 3.2% for the Arkray analyzer and 1.2% for the Bio-Rad analyzer. The Spearman correlation coefficient (r) was 0.973 (p

PDF

___

Misra A, Garg S. HbA1c and blood glucose for the diagnosis of diabetes. Lancet. 2011;378:104-6.

Rifai N, Horvath AR, Wittwer CT. Tietz textbook of clinical chemistry and molecular diagnostics. In: Diabetes Mellitus. 6th edition. Elsevier, 2018;1160-94.

Gillett MJ. International expert committee report on the role of the A1C Assay in the diagnosis of diabetes: diabetes care 2009;32:1327-34.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:81-90.

Cohen H, Zohar J, Gidron Y, et al. Blunted HPA axis response to stress ınfluences susceptibility to posttraumatic stress response in rats. Biol Psychiatry. 2006;59:1208-18.

Marshall SM, Barth JH. Standardization of HbA(1c) measurements: A consensus statement. Ann Clin Biochem. 2000;37:45-6.

Miedema K. Laboratory tests in diagnosis and management of diabetes mellitus. Practical considerations. Clin Chem Lab Med. 2003;41:1259–65.

Badiou S, Guillot J, Kuster N, et al. Comparison of Arkray/ELITech ADAMS HA-8180V® with Bio-Rad Variant,TMII Turbo2.0® and Tosoh Bioscience HLC®-723G8 for HbA1c Determination. J Clin Lab Anal. 2014;28:428-34.

Goodall I, Colman PG, Schneider HG, et al. Desirable performance standards for HbA1c analysis - Precision, accuracy and standardisation: Consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of A. Clin Chem Lab Med. 2007;45:1083-97.

10. Jones TG, Warber KD, Roberts BD. Analysis of Hemoglobin A1c from Dried Blood Spot Samples with the Tina-quant. J Diabetes Sci Technol. 2010;4:1-6.

11. Carey RN. CLSI EP15-A3: verification of precision and estimation of bias. https://www.westgard.com/clsi-ep15a3.htm

12. Madenci ÖÇ, Orçun A, Yildiz Z, et al. Evaluation of new Beckman Coulter 25(OH) Vitamin D assay and potential improvement of clinical interpretation. Biochem Medica. 2017;27:332-41.

13. Weykamp C, John WG, Mosca A. A review of the challenge in measuring hemoglobin A1c. J Diabetes Sci Technol. 2009;3:439-45.

14. Ejilemele A, Unabia J, Ju H, et al. A1c Gear: Laboratory quality HbA1c measurement at the point of care. Clin Chim Acta. 2015;445:139-42.

15. Shubrook J, Butts A, Chamberlain JJ, et al. Standards of medical care in diabetes—2017 abridged for primary care providers. Clin Diabetes. 2017;35:5–26.

16. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva: World Health Organization; 2011. https://www.ncbi.nlm.nih.gov/ books/NBK304267/itle

17. Tran D V., Lyon AW, Higgins TN, et al. Use of serial patient hemoglobin A1c differences to determine long-term imprecision of immunoassay and high-performance liquid chromatography analyzers. J. Diabetes Sci Technol. 2009;3:424-8.

18. Christy AL, Manjrekar PA, Babu RP, et al. Influence of iron deficiency anemia on hemoglobin A1C levels in diabetic individuals with controlled plasma glucose levels. Iran Biomed J. 2014;18:88-92.

19. Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC Reference System for Measurement of Hemoglobin A<sub>1c</sub> in Human Blood and the National Standardization Schemes in the United States, Japan, and Sweden: A Method-Comparison Study. Clin Chem. 2004;50:166-74.

20. Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57:1-47.

21. Roth J, Müller N, Lehmann T, et al. Comparison of HbA 1c measurements using 3 methods in 75 patients referred to one outpatient department. Exp Clin Endocrinol Diabetes. 2018;126:23-6.

22. Nyenwe EA, Fisher JN. A mistaken diagnosis of type 2 diabetes due to hemoglobin N-baltimore. Am J Med Sci. 2008;336:524–6.